Author

Dan Hu

Observed name: Hu, Dan

Institution: Shanghai University of Traditional Chinese Medicine

Observed institution: Shanghai University of Traditional Chinese Medicine

ORCID: 0009-0000-7946-7575

Observed ORCID: 0009-0000-7946-7575

OpenAlex ID: A5133684362

Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al. · Cancer Research · 3

Figure S8 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Supplemental Video S3 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Figure S9 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Figure S1 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Figure S3 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Figure S2 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Table S1 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Supplemental Video S4 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Figure S5 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Figure S10 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Table S6 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Supplemental Video S2 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Table S3 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Figure S7 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Figure S6 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Table S5 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Table S4 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Figure S4 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Table S2 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Supplemental Video S1 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Supplemental Video S5 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Data from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy

2026 · Cheng Fang, Guanglei Li, et al.

Works count: 24

Citation count: 3

H-index: 1

I10-index: